The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions
Abstract
Sodium‐glucose cotransporter 2 (SGLT2) inhibitors are a unique class of oral anti‐hyperglycaemic medications that act to reduce glucose reabsorption in the renal proximal tubules, thereby enhancing urinary glucose excretion. Large randomized placebo‐controlled trials in people with diabetes at high cardiovascular risk have demonstrated that SGLT2 inhibitors reduce heart failure hospitalization within months of commencing therapy. These findings...
Paper Details
Title
The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions
Published Date
Aug 10, 2019
Journal
Volume
6
Issue
5
Pages
927 - 935
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History